Table 3. The HBV-ACLFD model development based on predictors of mortality at baseline and their daily changes (Δ) within 7 days after diagnosis.
| Variables | OR | CI1 | CI2 | β-coefficient | P values |
|---|---|---|---|---|---|
| Ln (TBiL, μmol/L) | 3.02 | 0.99 | 9.22 | 1.11 | 0.052 |
| ΔLn (TBiL, μmol/L) | 3928.33 | 1.71 | 9.02e+06 | 8.28 | 0.036* |
| Ln (Albumin, g/L) | 0.93 | 0.84 | 1.02 | -0.08 | 0.110 |
| ΔLn (Albumin, g/L) | 0.69 | 0.46 | 1.02 | -0.38 | 0.063 |
| Ln (INR) | 2.25 | 0.56 | 9.05 | 0.81 | 0.255 |
| ΔLn (INR) | 9910.49 | 23.74 | 4.14e+06 | 9.20 | 0.003* |
| Ln (Blood neutrophils percentage count) | 1.06 | 1.02 | 1.10 | 0.06 | 0.001* |
| ΔLn (Blood neutrophils percentage count) | 1.38 | 1.13 | 1.68 | 0.32 | 0.002* |
| HE | |||||
| I-II | 0.97 | 0.38 | 2.52 | -0.03 | 0.957 |
| III-IV | 3.47 | 1.00 | 12.09 | 1.24 | 0.051 |
| Suspicion of infection | 0.37 | 0.15 | 0.87 | -1.00 | 0.022* |
| Constant | 0.00 | 0.00 | 0.02 | -10.27 | 0.002* |
*p<0.05.